ReviewFrontiers in immunology2026
Piezo1 in immune cells: from mechanosensation to immunoregulation.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The immune system is central to host defense against pathogens and the maintenance of organismal homeostasis. Immune cells often reside in or migrate through tissue microenvironments characterized by significant mechanical activity, where they are continuously subjected to diverse mechanical stimuli. Despite the ubiquity of mechanical signals in such contexts, the precise regulatory mechanisms by which these signals control immune cell function in a context-dependent manner remain incompletely understood. Main body: In recent years, the mechanosensitive ion channel Piezo1 has emerged as a core component of cellular mechanical sensing system, attracting considerable attention in immunology. This review integrates the latest research advances to systematically analyze the role of Piezo1 in both innate and adaptive immune cells. We discuss how Piezo1 is widely involved in key immune processes, including cell activation, differentiation, and functional regulation, and highlight the context-dependent nature of Piezo1 signaling, which can drive divergent immune outcomes depending on cellular lineage and pathological microenvironment. Conclusions: By synthesizing the current evidence, this review provides a theoretical foundation for understanding mechanical signaling in immunity. Crucially, this underscores that the functional duality and context-dependency of Piezo1 present both opportunities and challenges for drug targeting, offering insights for the development of precision immunotherapies that account for specific pathological settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.